Heidi Guyer, Heather Ringeisen, Jill Dever, Dan Liao, Andy Peytchev, Christine Carr, Paul Geiger, Leyla Stambaugh, Tim Smith, Lisa Dixon, Mark Olfson, Michael First, Scott Stroup, Lydia Chwastiak, Maria Monroe-Devita, Jeff Swanson, Marvin Swartz, Ronald C. Kessler, Robert Gibbons, Natalie Bareis, Elizabeth Sinclair Hancq, Thomas Clarke, Mark Edlund, the MDPS Consortium
{"title":"精神和药物使用障碍患病率研究：背景与方法","authors":"Heidi Guyer, Heather Ringeisen, Jill Dever, Dan Liao, Andy Peytchev, Christine Carr, Paul Geiger, Leyla Stambaugh, Tim Smith, Lisa Dixon, Mark Olfson, Michael First, Scott Stroup, Lydia Chwastiak, Maria Monroe-Devita, Jeff Swanson, Marvin Swartz, Ronald C. Kessler, Robert Gibbons, Natalie Bareis, Elizabeth Sinclair Hancq, Thomas Clarke, Mark Edlund, the MDPS Consortium","doi":"10.1002/mpr.2000","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>The Mental and Substance Use Disorders Prevalence Study (MDPS) builds upon previous epidemiologic studies to provide estimates of prevalence and treatment rates of mental and substance use disorders among adults aged 18–65 in the U.S. The study background and methods are described.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>The MDPS employed novel techniques such as the inclusion of household, prison, homeless and state psychiatric hospital populations, a semi-structured clinical interview administered by trained clinical interviewers to assess disorders, the assessment of both past year and lifetime schizophrenia spectrum disorder (SSD) using full Diagnostic and Statistical Manual 5 criteria, as well as other mental and substance use disorders, and video-based interviewing. Population specific and combined sample weights were developed to estimate nationally representative prevalence and treatment rates.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Data collection was conducted between October 2020 and October 2022 resulting in 5679 clinical interviews. The statistical weighting and analytic plan are described. Weighted response rates and reasons for non-response are provided for each study population.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The MDPS successfully developed and employed novel techniques to estimate the prevalence and treatment rates of mental and substance use disorders in both household and non-household populations, including some of the most impairing disorders such as SSD.</p>\n </section>\n </div>","PeriodicalId":50310,"journal":{"name":"International Journal of Methods in Psychiatric Research","volume":"33 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mpr.2000","citationCount":"0","resultStr":"{\"title\":\"Mental and Substance Use Disorders Prevalence Study: Background and Methods\",\"authors\":\"Heidi Guyer, Heather Ringeisen, Jill Dever, Dan Liao, Andy Peytchev, Christine Carr, Paul Geiger, Leyla Stambaugh, Tim Smith, Lisa Dixon, Mark Olfson, Michael First, Scott Stroup, Lydia Chwastiak, Maria Monroe-Devita, Jeff Swanson, Marvin Swartz, Ronald C. Kessler, Robert Gibbons, Natalie Bareis, Elizabeth Sinclair Hancq, Thomas Clarke, Mark Edlund, the MDPS Consortium\",\"doi\":\"10.1002/mpr.2000\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>The Mental and Substance Use Disorders Prevalence Study (MDPS) builds upon previous epidemiologic studies to provide estimates of prevalence and treatment rates of mental and substance use disorders among adults aged 18–65 in the U.S. The study background and methods are described.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Method</h3>\\n \\n <p>The MDPS employed novel techniques such as the inclusion of household, prison, homeless and state psychiatric hospital populations, a semi-structured clinical interview administered by trained clinical interviewers to assess disorders, the assessment of both past year and lifetime schizophrenia spectrum disorder (SSD) using full Diagnostic and Statistical Manual 5 criteria, as well as other mental and substance use disorders, and video-based interviewing. Population specific and combined sample weights were developed to estimate nationally representative prevalence and treatment rates.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Data collection was conducted between October 2020 and October 2022 resulting in 5679 clinical interviews. The statistical weighting and analytic plan are described. Weighted response rates and reasons for non-response are provided for each study population.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>The MDPS successfully developed and employed novel techniques to estimate the prevalence and treatment rates of mental and substance use disorders in both household and non-household populations, including some of the most impairing disorders such as SSD.</p>\\n </section>\\n </div>\",\"PeriodicalId\":50310,\"journal\":{\"name\":\"International Journal of Methods in Psychiatric Research\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-01-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mpr.2000\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Methods in Psychiatric Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/mpr.2000\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Methods in Psychiatric Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mpr.2000","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Mental and Substance Use Disorders Prevalence Study: Background and Methods
Objective
The Mental and Substance Use Disorders Prevalence Study (MDPS) builds upon previous epidemiologic studies to provide estimates of prevalence and treatment rates of mental and substance use disorders among adults aged 18–65 in the U.S. The study background and methods are described.
Method
The MDPS employed novel techniques such as the inclusion of household, prison, homeless and state psychiatric hospital populations, a semi-structured clinical interview administered by trained clinical interviewers to assess disorders, the assessment of both past year and lifetime schizophrenia spectrum disorder (SSD) using full Diagnostic and Statistical Manual 5 criteria, as well as other mental and substance use disorders, and video-based interviewing. Population specific and combined sample weights were developed to estimate nationally representative prevalence and treatment rates.
Results
Data collection was conducted between October 2020 and October 2022 resulting in 5679 clinical interviews. The statistical weighting and analytic plan are described. Weighted response rates and reasons for non-response are provided for each study population.
Conclusions
The MDPS successfully developed and employed novel techniques to estimate the prevalence and treatment rates of mental and substance use disorders in both household and non-household populations, including some of the most impairing disorders such as SSD.
期刊介绍：
The International Journal of Methods in Psychiatric Research (MPR) publishes high-standard original research of a technical, methodological, experimental and clinical nature, contributing to the theory, methodology, practice and evaluation of mental and behavioural disorders. The journal targets in particular detailed methodological and design papers from major national and international multicentre studies. There is a close working relationship with the US National Institute of Mental Health, the World Health Organisation (WHO) Diagnostic Instruments Committees, as well as several other European and international organisations.
MPR aims to publish rapidly articles of highest methodological quality in such areas as epidemiology, biostatistics, generics, psychopharmacology, psychology and the neurosciences. Articles informing about innovative and critical methodological, statistical and clinical issues, including nosology, can be submitted as regular papers and brief reports. Reviews are only occasionally accepted.
MPR seeks to monitor, discuss, influence and improve the standards of mental health and behavioral neuroscience research by providing a platform for rapid publication of outstanding contributions. As a quarterly journal MPR is a major source of information and ideas and is an important medium for students, clinicians and researchers in psychiatry, clinical psychology, epidemiology and the allied disciplines in the mental health field.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
